Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section listing Michigan, Utah, Washington, and Wisconsin. Removed the separate Michigan, Utah, Washington, and Wisconsin Locations sections and the HHS Vulnerability Disclosure link; updated the page to revision v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T21:08:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Publication notes now say that publications are automatically filled from PubMed and may or may not be about the study. The Revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:47:34.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the banner about government funding lapse and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:24:05.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content remains unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:03:08.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.
    Difference
    3%
    Check dated 2025-10-06T08:11:46.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:42:50.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.